PHASEBIO PHARMACEUTICALS INC's ticker is PHAS and the CUSIP is 717224109. A total of 39 filers reported holding PHASEBIO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,000 | -66.7% | 3,825 | 0.0% | 0.00% | – |
| Q2 2022 | $3,000 | -95.9% | 3,825 | 0.0% | 0.00% | – |
| Q1 2022 | $74,000 | +640.0% | 3,825 | 0.0% | 0.00% | – |
| Q4 2021 | $10,000 | -16.7% | 3,825 | 0.0% | 0.00% | – |
| Q3 2021 | $12,000 | +20.0% | 3,825 | +35.4% | 0.00% | – |
| Q2 2021 | $10,000 | 0.0% | 2,825 | 0.0% | 0.00% | – |
| Q1 2021 | $10,000 | 0.0% | 2,825 | 0.0% | 0.00% | – |
| Q4 2020 | $10,000 | -9.1% | 2,825 | 0.0% | 0.00% | – |
| Q3 2020 | $11,000 | -15.4% | 2,825 | 0.0% | 0.00% | – |
| Q2 2020 | $13,000 | +85.7% | 2,825 | +41.2% | 0.00% | – |
| Q1 2020 | $7,000 | – | 2,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|